MATK encodes the megakaryocyte-associated tyrosine-protein kinase that can phosphorylate and inactivate the SRC protein, which is one of the 5 markers used in ProExTMBr for breast cancer prognosis, in vitro [12]. This evidence concerns the gene SRC and breast carcinoma.